Basics Amneal Pharmaceuticals, Inc. IPO Date: January 1, 1900 Sector: Healthcare Industry: Biotech Market Cap: $3.83B Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 2.46% Avg Daily Range (30 D): $0.21 | 1.90% Avg Daily Range (90 D): $0.16 | 1.58% Institutional Daily Volume Avg Daily Volume: .4M Avg Daily Volume (30 D): 1.49M Avg Daily Volume (90 D): 1.37M Trade Size Avg Trade Size (Sh.): 146 Avg Trade Size (Sh.) (30 D): 89 Avg Trade Size (Sh.) (90 D): 93 Institutional Trades Total Inst.Trades: 1,821 Avg Inst. Trade: $1.61M Avg Inst. Trade (30 D): $2.24M Avg Inst. Trade (90 D): $2.34M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.78M Avg Closing Trade (30 D): $2.71M Avg Closing Trade (90 D): $2.71M Avg Closing Volume: 209.48K     News Dec 5, 2025 @ 1:00 PM Amneal Announces Positive Interim Phase 4 ELEVATE-... Source: Amneal Pharmaceuticals Dec 2, 2025 @ 1:00 PM Amneal to Participate in Upcoming Investor Confere... Source: Anthony Dimeo Oct 9, 2025 @ 1:31 PM Teva, Viatris On Investor Watch As White House Spa... Source: Vandana Singh Oct 2, 2025 @ 1:06 PM 3 Lesser-Known Healthcare Names With Major Upside ... Source: Nathan Reiff Sep 26, 2025 @ 12:00 PM Amneal Announces BLA Submission of Biosimilar Cand... Source: Amneal Pharmaceuticals Financials   TTM Q3 2025 Q2 2025 Basic EPS $.02 $.01 $.07 Diluted EPS $.01 $.01 $.07 Revenue $ 2.93B $ 784.51M $ 724.51M Gross Profit $ 1.08B $ 273.97M $ 286.25M Net Income / Loss $ 57.62M $ 18.13M $ 35.61M Operating Income / Loss $ 357.86M $ 70.34M $ 111.37M Cost of Revenue $ 1.86B $ 510.54M $ 438.26M Net Cash Flow $ 160.06M $ 154.74M $ 15.28M PE Ratio 1,218.00     Splits Aug 26, 2013:   1:25